,

Club Drugs and Novel Psychoactive Substances

The Clinician's Handbook

Specificaties
Paperback, 150 blz. | Engels
Cambridge University Press | e druk, 2020
ISBN13: 9781911623090
Rubricering
Cambridge University Press e druk, 2020 9781911623090
Verwachte levertijd ongeveer 9 werkdagen

Samenvatting

Over the last decade many hundreds of new psychoactive drugs have emerged onto illicit markets. This flood of new drugs has led to clinicians being unsure of the rapidly emerging changing evidence base and uncertain of the best approaches to assessment and clinical management. This book provides a concise, accessible summary of these emerging drugs. By categorizing the hundreds of new drugs by their predominant psychoactive effect - sedative, stimulant and hallucinogenic - the book helps clinicians to manage a drug they are unfamiliar with by using their experience of other drugs with similar psychoactive properties. Written for clinicians from across the frontline, from A&E staff to drug treatment professionals, the authors draw on numerous clinical examples from their own clinical experiences to illustrate aspects of assessment and management. Club drugs and novel psychoactive substances will continue to challenge clinicians and this handbook provides readers with an invaluable introduction to this complex area.

Specificaties

ISBN13:9781911623090
Taal:Engels
Bindwijze:Paperback
Aantal pagina's:150

Inhoudsopgave

Part I: 1. Introduction 2. What are NPS and Club Drugs and why are they important; 3. A brief history of NPS production and distribution; 4. Drugs classification framework for Club Drugs and NPS; 5. Clinical challenge of Club Drugs and NPS; Part II. Stimulant Drugs; 6. Stimulant drugs: introduction; 7. Stimulant drugs: cocaine; 8. Stimulant drugs: amphetamine-type; 9. Stimulant drugs: methamphetamine; 10. Stimulant drugs: MDMA; 11. Stimulant drugs: synthetic cathinones; Part III. Depressant Drugs; 12. Depressant drugs: introduction; 13. Depressant drugs: GHB/GBL; 14. Depressant drugs: Fentanyl, Fentanyl analogues and other opioid NPS; 15. Depressant drugs: Benzodiazepine NPS; 16. Depressant drugs: Ketamine and its anaologues; Part IV. Synthetic Cannabinoid Receptor Agonsits; 17. Synthetic cannabinoid receptor agonists (SCRAs); Part V. Hallucinogens; 18. Hallucinogens; Part VI. Concluding Remarks and References; 19. Concluding Remarks; 20. References.

Rubrieken

    Personen

      Trefwoorden

        Club Drugs and Novel Psychoactive Substances